Iodinolsept (Solution) Instructions for Use
Marketing Authorization Holder
Lekar, LLC (Russia)
ATC Code
D08AG (Iodine preparations)
Active Substance
Iodine (Ph.Eur. European Pharmacopoeia)
Dosage Form
| Iodinolsept | Solution for topical and external use: fl. 25 ml, 30 ml, 50 ml, 100 ml, 150 ml, 200 ml or 250 ml. |
Dosage Form, Packaging, and Composition
Solution for topical and external use: a dark blue liquid with a characteristic odor, foaming when shaken. Traces of foaming on the unfilled part of the bottle are allowed.
| 1 L | |
| Iodine | 1 g |
Excipients: potassium iodide – 3 g, polyvinyl alcohol – 9 g, purified water up to 1 L.
25 ml – bottles (1) – cardboard packs.
25 ml – bottles (1) – cardboard packs (with a spray nozzle).
30 ml – bottles (1) – cardboard packs.
30 ml – bottles (1) – cardboard packs (with a spray nozzle).
50 ml – bottles (1) – cardboard packs.
50 ml – bottles (1) – cardboard packs (with a spray nozzle).
100 ml – bottles (1) – cardboard packs.
100 ml – bottles (1) – cardboard packs (with a spray nozzle).
150 ml – bottles (1) – cardboard packs.
150 ml – bottles (1) – cardboard packs (with a spray nozzle).
200 ml – bottles (1) – cardboard packs.
200 ml – bottles (1) – cardboard packs (with a spray nozzle).
250 ml – bottles (1) – cardboard packs.
250 ml – bottles (1) – cardboard packs (with a spray nozzle).
Clinical-Pharmacological Group
Antiseptic for external and topical use
Pharmacotherapeutic Group
Antiseptic
Pharmacological Action
Elemental Iodine has pronounced antimicrobial properties. Preparations of elemental iodine are characterized by a pronounced local irritant effect on tissues, and in high concentrations, by a cauterizing effect. The local action is due to the ability of elemental iodine to precipitate tissue proteins. Preparations that release elemental Iodine have a significantly less pronounced irritant effect, while iodides have local irritant properties only in very high concentrations.
Pharmacokinetics
Upon contact with the skin or mucous membranes, 30% is converted into iodides, and the remainder into active Iodine. Partially absorbed. The absorbed part penetrates into tissues and organs and is selectively absorbed by the thyroid gland. It is excreted mainly by the kidneys, intestines, sweat and mammary glands.
Indications
For external use: infectious and inflammatory skin lesions, injuries, wounds, myalgia.
For topical use: chronic tonsillitis, atrophic rhinitis, purulent otitis, trophic and varicose ulcers, wounds, infected burns, fresh thermal and chemical burns of I-II degree.
ICD codes
| ICD-10 code | Indication |
| H66 | Suppurative and unspecified otitis media |
| I83.2 | Varicose veins of lower extremities with ulcer and inflammation |
| J31.0 | Chronic rhinitis (including ozaena, atrophic and hypertrophic rhinitis) |
| J35.0 | Chronic tonsillitis |
| L01 | Impetigo |
| L08.0 | Pyoderma |
| L08.8 | Other specified local infections of skin and subcutaneous tissue |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| M79.1 | Myalgia |
| T14.0 | Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect) |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| ICD-11 code | Indication |
| 1B72.0 | Bullous impetigo |
| 1B72.1 | Nonbullous impetigo |
| 1B72.Z | Impetigo, unspecified |
| 1B7Y | Other specified pyogenic bacterial infections of skin or subcutaneous tissue |
| 1C44 | Non-pyogenic bacterial infections of skin |
| AA9Z | Unspecified suppurative otitis media |
| BD74.Z | Chronic venous insufficiency of lower extremities, unspecified |
| CA09.0 | Chronic rhinitis |
| CA0F.Y | Other specified chronic diseases of the palatine tonsils and adenoids |
| EA40 | Tropical phagedenic ulcer |
| EA50.3 | Staphylococcal scarlet fever |
| EB21 | Pyoderma gangrenosum |
| EF60 | Ischemic ulceration of the skin |
| EH92 | Dermatoses provoked by friction or mechanical impact |
| EH92.1 | Blister due to friction |
| EM0Z | Unspecified skin disorder |
| FB56.2 | Myalgia |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| ND56.0 | Superficial injury of unspecified body region |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
It is used externally and topically.
For external use, the damaged areas of the skin are treated with iodine.
For topical use, it is used for washing lacunae and supratonsillar spaces, for irrigating the nasopharynx, for instillation into the ear and washing; in surgical practice and for burns, gauze napkins applied to the affected surface are moistened as needed. The doses, method of application, and duration of treatment are determined depending on the indications.
Adverse Reactions
Rarely skin irritation; with prolonged use on large surfaces – iodism (rhinitis, urticaria, angioedema, salivation, lacrimation, acne).
Contraindications
Hypersensitivity to iodine.
For external use: thyrotoxicosis, dermatitis herpetiformis.
Use in Pregnancy and Lactation
It is used according to indications during pregnancy and breastfeeding.
Use in Hepatic Impairment
It is used according to indications.
Use in Renal Impairment
It is used according to indications.
Pediatric Use
It is used according to indications.
Geriatric Use
It is used according to indications.
Special Precautions
With prolonged use, phenomena of iodism are possible.
Drug Interactions
Pharmaceutically incompatible with essential oils, ammonia solutions, white precipitated mercury (forms an explosive mixture).
An alkaline or acidic environment, the presence of fat, pus, and blood weaken the antiseptic activity.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Belosalic, lotion solution for external use spray 100ml
No-spa pills 40mg, 64pcs
Arbidol, capsules 100mg, 40pcs
Noopept, pills 10mg, 50pcs
Fenotropil pills 100mg, 60pcs
Kagocel pills 12mg, 30pcs
OKI, sachets 80mg 2g, 12pcs
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Mildronate capsules 500mg, 90pcs
Nootropil pills 800mg, 30pcs 